The Dual role of Interleukin-25 in the control of immune-mediated pathologies

Current Molecular Medicine

Volumn 11, Issue 1, 2011, Pages 26-30

  Caruso, R ^a   Stolfi, C ^a   de Nitto, D ^a   Pallone, F ^a   Monteleone, G ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Allergic diseases; Diabetes; IBD; IL 25; Multiple sclerosis; Th cells

Indexed keywords

INTERLEUKIN 25;

ALLERGY; ARTICLE; AUTOIMMUNE DISEASE; ENDOTHELIUM CELL; HELPER CELL; HOST CELL; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MACROPHAGE ACTIVATION; MULTIPOTENT STEM CELL; NATURAL KILLER CELL; NONHUMAN; PROTEIN FUNCTION; PROTEIN SYNTHESIS; T LYMPHOCYTE; TH1 CELL; TH17 CELL;

ANIMALS; DIABETES MELLITUS; HUMANS; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-17; MULTIPLE SCLEROSIS; RECEPTORS, INTERLEUKIN-17; T-LYMPHOCYTES, HELPER-INDUCER; UP-REGULATION;

EID: 79551659479     PISSN: 15665240     EISSN: None     Source Type: Journal    
DOI: 10.2174/156652411794474365     Document Type: Article

References (50)

1. Chaplin DD. Overview of the immune response. J Allergy Clin Immunol 2010; 125: S3-23.
2. Trinchieri G. Interleukin-12 and the regulation of innateresistance and adaptive immunity. Nat Rev Immunol 2003; 3: 133-46.
3. Damsker JM, Hansen AM, Caspi RR. Th1 and Th 17 cells:adversaries and collaborators. Ann N Y Acad Sci 2010; 1183: 211-21.
4. Zhu J, Paul WE. Heterogeneity and plasticity of T helpercells. Cell Res 2010; 20: 4-12.
5. de Jong E, Suddason T, Lord GM. Translational mini-reviewseries on Th 17 cells: development of mouse and human Thelper 17 cells. Clin Exp Immunol 2010; 159: 148-58.
6. Monteleone G, Biancone L, Marasco R, et al. Interleukin 12is expressed and actively released by Crohn's diseaseintestinal lamina propria mononuclear cells. Gastroenterology 1997; 112: 1169-78.
7. Nalbandian A, Crispin JC, Tsokos GC. Interleukin-17 andsystemic lupus erythematosus: current concepts. Clin Exp Immunol 2009; 157: 209-15.
8. Zheng Y, Danilenko DM, Valdez P, et al. Interleukin-22, aT(H)17 cytokine, mediates IL-23-induced dermalinflammation and acanthosis. Nature 2007; 445: 648-51.
9. Zaph C, Du Y, Saenz SA, et al. Commensal-dependentexpression of IL-25 regulates the IL-23-IL-17 axis in theintestine. J Exp Med 2008; 205: 2191-8.
10. Fort MM, Cheung J, Yen D, et al. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 2001; 15: 985-95.
11. Angkasekwinai P, Park H, Wang YH, et al. Interleukin 25promotes the initiation of proallergic type 2 responses. J Exp Med 2007; 204: 1509-17.
12. Caruso R, Sarra M, Stolfi C, et al. Interleukin-25 inhibitsinterleukin-12 production and Th1 cell-driven inflammation inthe gut. Gastroenterology 2009; 136: 2270-9.
13. Sonobe Y, Takeuchi H, Kataoka K, et al. Interleukin-25expressed by brain capillary endothelial cells maintainsblood-brain barrier function in a protein kinase Cepsilondependentmanner. J Biol Chem 2009; 284: 31834-42.
14. Emamaullee JA, Davis J, Merani S, et al. Inhibition of Th 17cells regulates autoimmune diabetes in NOD mice. Diabetes 2009; 58: 1302-11.
15. Ikeda K, Nakajima H, Suzuki K, et al. Mast cells produceinterleukin-25 upon Fc epsilon RI-mediated activation. Blood 2003; 101: 3594-6.
16. Kang CM, Jang AS, Ahn MH, et al. Interleukin-25 andinterleukin-13 production by alveolar macrophages inresponse to particles. Am J Respir Cell Mol Biol 2005; 33: 290-6.
17. Dolgachev V, Petersen BC, Budelsky AL, Berlin AA, Lukacs NW. Pulmonary IL-17E (IL-25) production and IL-17RB+myeloid cell-derived Th2 cytokine production are dependentupon stem cell factor-induced responses during chronicallergic pulmonary disease. J Immunol 2009; 183: 5705-15.
18. Wang YH, Angkasekwinai P, Lu N, et al. IL-25 augmentstype 2 immune responses by enhancing the expansion andfunctions of TSLP-DC-activated Th2 memory cells. J Exp Med 2007; 204: 1837-47.
19. D Fina, E Franzè, L Rovedatti, et al. Interleukin-25production is differently regulated by TNF-α and TGF-β1 inthe human gut. Mucosal Immunol 2010 Oct 13. [Epub aheadof print]
20. Ely LK, Fischer S, Garcia KC. Structural basis of receptorsharing by interleukin 17 cytokines. Nat Immunol 2009; 10: 1245-51.
21. Caruso R, Stolfi C, Sarra M, et al. Inhibition of monocytederivedinflammatory cytokines by IL-25 occurs via p38 Mapkinase-dependent induction of Socs-3. Blood 2009; 113: 3512-9.
22. Terashima A, Watarai H, Inoue S, et al. A novel subset ofmouse NKT cells bearing the IL-17 receptor B responds to IL-25 and contributes to airway hyperreactivity. J Exp Med 2008; 205: 2727-33.
23. Stock P, Lombardi V, Kohlrautz V, Akbari O. Induction ofairway hyperreactivity by IL-25 is dependent on a subset ofinvariant NKT cells expressing IL-17RB. J Immunol 2009; 182: 5116-22.
24. Wong CK, Cheung PF, Ip WK, Lam CW. Interleukin-25-induced chemokines and interleukin-6 release fromeosinophils is mediated by p38 mitogen-activated proteinkinase, c-Jun N-terminal kinase, and nuclear factor-kappaB. Am J Respir Cell Mol Biol 2005; 33: 186-94.
25. Maezawa Y, Nakajima H, Suzuki K, et al. Involvement of TNF receptor-associated factor 6 in IL-25 receptor signaling. J Immunol 2006; 176: 1013-8.
26. Chang SH, Park H, Dong C. Act1 adaptor protein is animmediate and essential signaling component of interleukin-17 receptor. J Biol Chem 2006; 281: 35603-7.
27. Swaidani S, Bulek K, Kang Z, et al. The critical role ofepithelial-derived Act1 in IL-17- and IL-25-mediatedpulmonary inflammation. J Immunol 2009; 182: 1631-40.
28. Louten J, Boniface K, de Waal Malefyt R. Development andfunction of TH 17 cells in health and disease. J Allergy Clin Immunol 2009; 123: 1004-11.
29. Hurst SD, Muchamuel T, Gorman DM, et al. New IL-17 familymembers promote Th1 or Th2 responses in the lung: in vivofunction of the novel cytokine IL-25. J Immunol 2002; 169: 443-53.
30. Kim MR, Manoukian R, Yeh R, et al. Transgenicoverexpression of human IL-17E results in eosinophilia, Blymphocytehyperplasia, and altered antibody production. Blood 2002; 100: 2330-40.
31. Pan G, French D, Mao W, et al. Forced expression of murineIL-17E induces growth retardation, jaundice, a Th2-biasedresponse, and multiorgan inflammation in mice. J Immunol 2001; 167: 6559-67.
32. Sharkhuu T, Matthaei KI, Forbes E, et al. Mechanism ofinterleukin-25 (IL-17E)-induced pulmonary inflammation andairways hyper-reactivity. Clin Exp Allergy 2006; 36: 1575-83.
33. Shinkai K, Mohrs M, Locksley RM. Helper T cells regulatetype-2 innate immunity in vivo. Nature 2002; 420: 825-9.
34. Voehringer D, Shinkai K, Locksley RM. Type 2 immunityreflects orchestrated recruitment of cells committed to IL-4production. Immunity 2004; 20: 267-77.
35. Fallon PG, Ballantyne SJ, Mangan NE, et al. Identification ofan interleukin (IL)-25-dependent cell population that providesIL-4, IL-5, and IL-13 at the onset of helminth expulsion. J Exp Med 2006; 203: 1105-16.
36. Claudio E, Sonder SU, Saret S, et al. The adaptor proteinCIKS/Act1 is essential for IL-25-mediated allergic airwayinflammation. J Immunol 2009; 182: 1617-30.
37. Saenz SA, Siracusa MC, Perrigoue JG, et al. IL 25 elicits amultipotent progenitor cell population that promotes T(H)2cytokine responses. Nature 2010; 464: 1362-6.
38. Neill DR, Wong SH, Bellosi A, et al. Nuocytes represent anew innate effector leukocyte that mediates type-2 immunity. Nature 2010; 464: 1367-70.
39. Moro K, Yamada T, Tanabe M, et al. Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1 (+) lymphoid cells. Nature 2010; 463: 540-4.
40. Tamachi T, Maezawa Y, Ikeda K, et al. IL-25 enhancesallergic airway inflammation by amplifying a TH2 celldependentpathway in mice. J Allergy Clin Immunol 2006; 118: 606-14.
41. Jarnicki AG, Fallon PG. T helper type-2 cytokine responses:potential therapeutic targets. Curr Opin Pharmacol 2003; 3: 449-55.
42. Veldhoen M, Uyttenhove C, van Snick J, et al. Transforminggrowth factor-beta 'reprograms' the differentiation of T helper2 cells and promotes an interleukin 9-producing subset. Nat Immunol 2008; 9: 1341-6.
43. Angkasekwinai P, Chang SH, Thapa M, Watarai H, Dong C. Regulation of IL-9 expression by IL-25 signaling. Nat Immunol 2010; 11: 250-6.
44. Owyang AM, Zaph C, Wilson EH, et al. Interleukin 25regulates type 2 cytokine-dependent immunity and limitschronic inflammation in the gastrointestinal tract. J Exp Med 2006; 203: 843-9.
45. Kleinschek MA, Owyang AM, Joyce-Shaikh B, et al. IL-25regulates Th 17 function in autoimmune inflammation. J Exp Med 2007; 204: 161-70.
46. McHenga SS, Wang D, Li C, Shan F, Lu C. Inhibitory effectof recombinant IL-25 on the development of dextran sulfatesodium-induced experimental colitis in mice. Cell Mol Immunol 2008; 5: 425-31.
47. Letuve S, Lajoie-Kadoch S, Audusseau S, et al. IL-17Eupregulates the expression of proinflammatory cytokines inlung fibroblasts. J Allergy Clin Immunol 2006; 117: 590-6.
48. Paul WE, Zhu J. How are T(H)2-type immune responsesinitiated and amplified? Nat Rev Immunol 2010; 10: 225-35.
49. Bulek K, Swaidani S, Aronica M, et al. Epithelium: theinterplay between innate and Th2 immunity. Immunol Cell Biol 2010; 88: 257-68.
50. Barlow JL, McKenzie AN. IL-25: a key requirement for theregulation of type-2 immunity. Biofactors 2009; 35: 178-82.